|
- Medical Breakthrough Offers Hope To Those Fighting Addiction
A new drug that helps people with a substance dependency detoxification —in five days—from opioids and alcohol without painful withdrawal symptoms recently completed a proof-of-concept
- VCU researchers are developing a long-acting medication for . . .
In hope of providing more treatment options for opioid use disorder, the VCU research team reworked nor-levo-alpha-acetylmethadol, a metabolite of a previous FDA-approved opiate dependence medication, into a new formulation that could be used to help patients with opioid addiction
- FDA approves painkiller designed to . . . - Associated Press News
U S officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids
- FDA Approves New Buprenorphine Treatment Option for Opioid . . .
The U S Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)
- FDA OKs painkiller designed to end opioids addiction and . . .
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin
- FDA Approves New Drug for Opioid Use Disorder: Brixadi®
The FDA's approval of Brixadi® marks a significant milestone in the battle against opioid addiction This medication offers healthcare professionals and patients a new option for the treatment of opioid use disorder, with its extended-release formulation providing convenience and improved medication adherence
- New compound could supercharge naloxone in fight against . . .
Addiction July 03, 2024 New compound could supercharge naloxone in fight against opioid overdoses By Nina Bai In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone's ability to fend off more potent opioids, with promising results in mice
- New Strategies to Prevent and Treat Opioid Addiction
Overview The Helping to End Addiction Long-term ® Initiative, or NIH HEAL Initiative ®, supports a wide range of programs to develop new or improved prevention and treatment strategies for opioid addiction and co-occurring conditions such as mental illness and polysubstance use Programs are developing and implementing prevention and treatment strategies for a range of at-risk populations
|
|
|